Larry Ramer

Larry Ramer

InvestorPlace Contributor

Larry Ramer has more than 15 years of experience in business journalism. He has worked for Globes, Israel’s most widely read business newspaper, as well as The Jerusalem Post and theflyonthewall.

Mr. Ramer’s expansive knowledge of politics enables him to provide valuable insights into how politics can affect stocks. He also focuses on contrary investing and specializes in the renewable energy and consumer discretionary sectors.

Among his highly successful, contrarian picks have been Super Micro Computer, Intel, and MGM Resorts.

You can reach him on StockTwits at @larryramer and learn more about his stock-picking record at his TipRanks profile.

Recent Articles

3 Auto Stocks That Should Be on Every Investor’s Radar This Fall

By Larry Ramer, InvestorPlace Contributor

The best auto stocks to buy are those with low valuations and tremendous opportunities in areas such as electrification and software. 

NIO Stock Alert: The $1 Billion Reason Nio Is Down Today

By Larry Ramer, InvestorPlace Contributor

NIO stock is falling sharply in early trading. The electric vehicle (EV) maker issued $1 billion of convertible notes. 

3 Stocks to Short Now BEFORE They Plunge

By Larry Ramer, InvestorPlace Contributor

These stocks to short are flying high even though they're facing difficult problems. Their challenges will cause their stocks to fall. 

3 Stocks to Buy Now if You Think Fed Rate Cuts Are Still Coming

By Larry Ramer, InvestorPlace Contributor

With core CPI remaining in check, the Fed is likely to cut rates relatively soon. Here are three stocks to buy to exploit the coming cuts. 

Why Is T2 Biosystems (TTOO) Stock Up 30% Today?

By Larry Ramer, InvestorPlace Contributor

TTOO stock is climbing over 30% after the Food and Drug Administration ruled that T2 Biosystems can sell its new biothreat test. 

Load More